Author Correction: Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells

Nat Biomed Eng. 2024 Feb 12. doi: 10.1038/s41551-024-01181-y. Online ahead of print.

Sjoukje J C van der Stegen^{1

2}, Pieter L Lindenbergh^{1

2

3}, Roseanna M Petrovic^{1

2}, Hongyao Xie^{1

2}, Mame P Diop^{1

2}, Vera Alexeeva^{1

2}, Yuzhe Shi^{1

2}, Jorge Mansilla-Soto^{1

2}, Mohamad Hamieh^{1

2}, Justin Eyquem^{1

2

4}, Annalisa Cabriolu^{1

2}, Xiuyan Wang⁵, Ramzey Abujarour⁶, Tom Lee⁶, Raedun Clarke⁶, Bahram Valamehr⁶, Maria Themeli³, Isabelle Riviere⁵, Michel Sadelain^{7

8}

¹ Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
³ Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Amsterdam, Amsterdam, the Netherlands.
⁴ Gladstone-UCSF Institute of Genomic Immunology, Gladstone Institutes, San Francisco, CA, USA.
⁵ Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Fate Therapeutics Inc, San Diego, CA, USA.
⁷ Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.
⁸ Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA. m-sadelain@ski.mskcc.org.

No abstract available

Publication types